Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Novartis H1N1 Vaccine in HIV-Positive Adults
NCT00992433Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Nov 2009
- Primary completion
- Nov 2010
- Modality
- Live Attenuated Vaccines, Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of Influenza A (H1N1) vaccine in influenza, sponsored by National Institute of Allergy and Infectious Diseases. Started Nov 2009; status: completed.
02
Drugs
Influenza A (H1N1) vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00992433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00992433.